Indiana Statutes

§ 12-21-9-7 — Application; clinical study requirements

Indiana·Art. 21 DIVISION OF MENTAL HEALTH AND·Ch. 9 Therapeutic Psilocybin Research
(a)A research institution in Indiana may apply to the division to receive financial assistance from the fund to conduct one (1) or more clinical studies to evaluate the efficacy of psilocybin and ibogaine as an alternative treatment for mental health and other medical conditions, including the following:
(1)Posttraumatic stress disorder, with a focus on treating the disorder in combat veterans and first responders.
(2)Anxiety.
(3)Depression.
(4)Bipolar disorder.
(5)Chronic pain.
(6)Migraines.
(7)Alcohol use disorder.
(8)Tobacco use disorder.
(b)In conducting a clinical study under this section, a research institution that receives a grant under this chapter shall do the following:
(1)Include veterans and first responders in the study sample.
(2)Evaluate and determine whether ps

Free access — add to your briefcase to read the full text and ask questions with AI

Indiana § 12-21-9-7 (Application; clinical study requirements) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

As added by P.L.152-2024, SEC.4. Amended by P.L.213-2025, SEC.126.

Nearby Sections

15
View on official source ↗